Asymmetry Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Asymmetry Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-49,431	Closed	-$1.18M	–	41
2019 Q4	$1.18M	Sell	49,431 -100,868	-67%	-$2.78M	2.12%	23
2019 Q3	$4.03M	Sell	150,299 -375,431	-71%	-$10.5M	8.64%	3
2019 Q2	$14.3M	Buy	525,730 +341,828	+186%	+$10.7M	7.72%	4
2019 Q1	$6.38M	Buy	183,902 +13,773	+8%	+$397K	10.66%	1
2018 Q4	$3.32M	Sell	170,129 -81,752	-32%	-$1.68M	9.18%	4
2018 Q3	$6.71M	Buy	251,881 +164,765	+189%	+$5.38M	6.2%	3
2018 Q2	$3.29M	Buy	+87,116	New	+$3.33M	3.23%	11

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Asymmetry Capital Management's PTLA Position: Q1 2020 in Review

Asymmetry Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 49,431 shares — an estimated $1.18M sold.

Asymmetry Capital Management first reported a position in PTLA in Q2 2018 and held it in 7 quarters. The position peaked at $14.3M in Q2 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Asymmetry Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Asymmetry Capital Management sold 49,431 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.18M.
Asymmetry Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2018 and held it in 7 quarters.
Asymmetry Capital Management's Portola Pharmaceuticals, Inc. position peaked at $14.3M in Q2 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Asymmetry Capital Management's 13F filing for Q1 2020, filed 13 May 2020.